About
Pliant Therapeutics Inc (NASDAQ:PLRX) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
Feb 23 2026
Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference
Dec 4 2025
Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors
Dec 1 2025
Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference
Nov 6 2025
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
Google Übersetzer